Picard Medical (PMI) FCF Margin (2024 - 2026)

Picard Medical's FCF Margin history runs 3 years deep, the most recent figure standing at 332.7% for Q1 2026.

• Quarterly FCF Margin rose 2876.0% year-over-year to 332.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 315.1% (down 5113.0% YoY) and the FY2025 annual result came in at 317.27%, down 4685.0% from the prior year.
• FCF Margin was 332.7% for Q1 2026 at Picard Medical, up from 433.8% in the prior quarter.
• Across five years, FCF Margin topped out at 119.24% in Q2 2025 and bottomed at 548.78% in Q3 2025.
• A 3-year average of 352.72% and a median of 361.45% in 2025 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2025 — FCF Margin slumped 25275 bps — and 2026, when it soared 2876 bps.
• Picard Medical's FCF Margin stood at 377.03% in 2024, then fell by 15 bps to 433.8% in 2025, then climbed by 23 bps to 332.7% in 2026.
• Business Quant data shows PMI's FCF Margin at 332.7% in Q1 2026, 433.8% in Q4 2025, and 548.78% in Q3 2025.